Summit Therapeutics Plc Stock Price History
| SMMT Stock | USD 19.75 0.31 1.59% |
Below is the normalized historical share price chart for Summit Therapeutics PLC extending back to March 04, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Summit Therapeutics stands at 19.75, as last reported on the 23rd of March, with the highest price reaching 20.02 and the lowest price hitting 19.14 during the day.
If you're considering investing in Summit Stock, it is important to understand the factors that can impact its price. Summit Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Summit Therapeutics PLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0434, which indicates the firm had a 0.0434 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Summit Therapeutics PLC, which you can use to evaluate the volatility of the company. Please review Summit Therapeutics' Semi Deviation of 4.98, coefficient of variation of 1813.78, and Risk Adjusted Performance of 0.0573 to confirm if our risk estimates are consistent with your expectations.
At this time, Summit Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 754.5 M in 2025, whereas Capital Stock is likely to drop slightly above 3.7 M in 2025. . Price Earnings To Growth Ratio is likely to gain to 0.89 in 2025, whereas Price To Sales Ratio is likely to drop 1,275 in 2025. Summit Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of March 2015 | 200 Day MA 16.8038 | 50 Day MA 20.2087 | Beta (1.04) |
Summit |
Sharpe Ratio = 0.0434
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SMMT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.37 actual daily | 47 53% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Summit Therapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Summit Therapeutics by adding it to a well-diversified portfolio.
Price Book 37.4392 | Enterprise Value Ebitda (5.32) | Price Sales 753.9008 | Shares Float 115.2 M | Wall Street Target Price 34.6274 |
Summit Therapeutics Stock Price History Chart
There are several ways to analyze Summit Stock price data. The simplest method is using a basic Summit candlestick price chart, which shows Summit Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 23, 2025 | 24.65 |
| Lowest Price | January 14, 2025 | 16.65 |
Summit Therapeutics March 23, 2025 Stock Price Synopsis
Various analyses of Summit Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Summit Stock. It can be used to describe the percentage change in the price of Summit Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Summit Stock.| Summit Therapeutics Price Rate Of Daily Change | 1.02 | |
| Summit Therapeutics Price Action Indicator | 0.32 | |
| Summit Therapeutics Price Daily Balance Of Power | 0.35 |
Summit Therapeutics March 23, 2025 Stock Price Analysis
Summit Stock Price History Data
The price series of Summit Therapeutics for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 has a statistical range of 8.0 with a coefficient of variation of 9.29. The price distribution for the period has arithmetic mean of 19.73. The median price for the last 90 days is 19.19. The company completed stock split (1:1) on 21st of September 2020.| Open | High | Low | Close | Volume | ||
03/23/2025 | 19.43 | 20.02 | 19.14 | 19.75 | ||
| 03/21/2025 | 19.43 | 20.02 | 19.14 | 19.75 | 3,192,750 | |
| 03/20/2025 | 19.62 | 20.21 | 19.39 | 19.44 | 1,400,939 | |
| 03/19/2025 | 19.78 | 20.29 | 19.18 | 20.11 | 1,728,958 | |
| 03/18/2025 | 19.89 | 20.53 | 19.16 | 19.83 | 1,850,685 | |
| 03/17/2025 | 20.79 | 20.85 | 20.07 | 20.13 | 1,787,774 | |
| 03/14/2025 | 19.49 | 21.29 | 19.20 | 20.79 | 3,187,325 | |
| 03/13/2025 | 19.79 | 20.59 | 19.06 | 19.19 | 2,229,969 | |
| 03/12/2025 | 19.27 | 20.45 | 19.27 | 19.91 | 2,742,244 | |
| 03/11/2025 | 17.91 | 18.87 | 17.42 | 18.50 | 2,778,925 | |
| 03/10/2025 | 17.18 | 18.39 | 16.55 | 17.99 | 3,503,436 | |
| 03/07/2025 | 18.87 | 18.97 | 17.71 | 17.78 | 3,403,879 | |
| 03/06/2025 | 18.89 | 19.92 | 18.51 | 18.99 | 1,885,352 | |
| 03/05/2025 | 18.91 | 19.59 | 18.76 | 19.55 | 1,574,635 | |
| 03/04/2025 | 18.54 | 19.37 | 18.34 | 19.09 | 2,618,696 | |
| 03/03/2025 | 20.80 | 21.38 | 18.84 | 19.13 | 2,820,274 | |
| 02/28/2025 | 18.74 | 20.77 | 18.50 | 20.69 | 2,807,591 | |
| 02/27/2025 | 18.60 | 19.26 | 17.97 | 18.49 | 2,199,652 | |
| 02/26/2025 | 18.53 | 19.55 | 18.27 | 18.30 | 2,825,097 | |
| 02/25/2025 | 19.19 | 19.20 | 17.70 | 18.11 | 3,679,289 | |
| 02/24/2025 | 22.46 | 22.71 | 18.52 | 18.84 | 6,899,400 | |
| 02/21/2025 | 23.80 | 24.18 | 21.81 | 22.12 | 3,318,553 | |
| 02/20/2025 | 21.52 | 23.13 | 21.40 | 23.06 | 3,287,239 | |
| 02/19/2025 | 20.99 | 21.63 | 20.69 | 21.60 | 1,352,878 | |
| 02/18/2025 | 21.52 | 21.72 | 20.43 | 21.08 | 1,754,400 | |
| 02/14/2025 | 22.14 | 22.14 | 20.79 | 21.37 | 2,335,889 | |
| 02/13/2025 | 19.75 | 22.75 | 19.45 | 21.82 | 3,467,873 | |
| 02/12/2025 | 18.70 | 19.62 | 18.42 | 19.57 | 2,096,200 | |
| 02/11/2025 | 20.50 | 20.63 | 18.90 | 19.08 | 1,867,630 | |
| 02/10/2025 | 20.57 | 21.59 | 20.30 | 20.50 | 1,533,091 | |
| 02/07/2025 | 20.50 | 20.95 | 19.85 | 20.11 | 1,345,566 | |
| 02/06/2025 | 20.87 | 21.47 | 20.63 | 20.67 | 1,134,315 | |
| 02/05/2025 | 20.69 | 21.56 | 20.43 | 20.78 | 1,427,666 | |
| 02/04/2025 | 20.00 | 20.89 | 19.90 | 20.62 | 1,764,900 | |
| 02/03/2025 | 20.54 | 21.00 | 19.83 | 19.98 | 2,335,700 | |
| 01/31/2025 | 22.92 | 22.98 | 21.02 | 21.50 | 2,138,700 | |
| 01/30/2025 | 21.89 | 22.76 | 21.55 | 22.36 | 1,457,600 | |
| 01/29/2025 | 23.38 | 23.89 | 21.61 | 21.64 | 1,850,000 | |
| 01/28/2025 | 23.89 | 24.17 | 22.76 | 23.50 | 1,730,200 | |
| 01/27/2025 | 22.53 | 23.56 | 22.32 | 23.52 | 1,808,300 | |
| 01/24/2025 | 25.00 | 25.00 | 23.39 | 23.76 | 2,602,500 | |
| 01/23/2025 | 22.96 | 25.00 | 22.85 | 24.65 | 2,798,800 | |
| 01/22/2025 | 22.38 | 24.21 | 22.38 | 23.52 | 4,454,200 | |
| 01/21/2025 | 19.25 | 22.11 | 19.25 | 22.10 | 4,404,900 | |
| 01/17/2025 | 18.52 | 19.39 | 18.33 | 19.03 | 2,589,500 | |
| 01/16/2025 | 18.18 | 18.50 | 17.68 | 18.19 | 2,136,500 | |
| 01/15/2025 | 17.27 | 18.24 | 17.12 | 18.20 | 2,569,200 | |
| 01/14/2025 | 18.48 | 18.57 | 16.46 | 16.65 | 3,256,900 | |
| 01/13/2025 | 17.50 | 18.32 | 17.03 | 18.18 | 1,783,700 | |
| 01/10/2025 | 18.58 | 18.91 | 16.72 | 17.85 | 3,324,100 | |
| 01/08/2025 | 18.45 | 19.39 | 18.10 | 18.82 | 3,180,300 | |
| 01/07/2025 | 17.62 | 18.20 | 17.37 | 18.16 | 1,784,500 | |
| 01/06/2025 | 18.33 | 18.55 | 17.41 | 17.47 | 2,069,800 | |
| 01/03/2025 | 18.25 | 18.61 | 18.06 | 18.24 | 1,846,800 | |
| 01/02/2025 | 17.97 | 18.89 | 17.75 | 18.35 | 2,121,300 | |
| 12/31/2024 | 17.94 | 18.31 | 17.17 | 17.85 | 2,239,600 | |
| 12/30/2024 | 17.89 | 18.15 | 17.53 | 17.89 | 1,248,500 | |
| 12/27/2024 | 19.01 | 19.30 | 17.98 | 18.21 | 1,713,000 | |
| 12/26/2024 | 18.75 | 19.55 | 18.63 | 19.28 | 1,386,500 | |
| 12/24/2024 | 18.88 | 19.08 | 18.33 | 19.00 | 760,600 | |
| 12/23/2024 | 17.97 | 18.90 | 17.61 | 18.67 | 2,276,200 |
About Summit Therapeutics Stock history
Summit Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Summit is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Summit Therapeutics PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Summit Therapeutics stock prices may prove useful in developing a viable investing in Summit Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 718.5 M | 754.5 M | |
| Net Loss | -70.9 M | -67.4 M |
Summit Therapeutics Quarterly Net Working Capital |
|
Summit Therapeutics Stock Technical Analysis
Summit Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Summit Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Summit Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Summit Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Summit to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0573 | |||
| Jensen Alpha | 0.4566 | |||
| Total Risk Alpha | 0.7025 | |||
| Sortino Ratio | 0.0702 | |||
| Treynor Ratio | 0.1169 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Summit Stock Analysis
When running Summit Therapeutics' price analysis, check to measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.